Cargando…
Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324671/ https://www.ncbi.nlm.nih.gov/pubmed/30647860 http://dx.doi.org/10.18632/oncotarget.26465 |
| _version_ | 1783386012784787456 |
|---|---|
| author | Bailey, Kelly M. |
| author_facet | Bailey, Kelly M. |
| author_sort | Bailey, Kelly M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6324671 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63246712019-01-15 Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma Bailey, Kelly M. Oncotarget News Impact Journals LLC 2018-12-18 /pmc/articles/PMC6324671/ /pubmed/30647860 http://dx.doi.org/10.18632/oncotarget.26465 Text en Copyright: © 2018 Bailey. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | News Bailey, Kelly M. Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma |
| title | Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma |
| title_full | Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma |
| title_fullStr | Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma |
| title_full_unstemmed | Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma |
| title_short | Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma |
| title_sort | prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in ewing sarcoma |
| topic | News |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324671/ https://www.ncbi.nlm.nih.gov/pubmed/30647860 http://dx.doi.org/10.18632/oncotarget.26465 |
| work_keys_str_mv | AT baileykellym prospectiveinvestigationofdrugresistanceanapproachtounderstandingandoptimizingtheclinicalbenefitoftargetedagentsinewingsarcoma |